Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study (P11-5.007)

Authors

Michele Tagliati (ORCID: https://orcid.org/0000-0002-6722-8208)
Fabrizio Stocchi (ORCID: https://orcid.org/0000-0002-5763-0033)
Alberto J. Espay (ORCID: https://orcid.org/0000-0002-3389-136X)
Harini Sarva (ORCID: https://orcid.org/0000-0002-0320-2893)
Olivier Rascol (ORCID: https://orcid.org/0000-0002-1410-6397)
Werner Poewe (ORCID: https://orcid.org/0000-0003-4367-0971)
Tami Yardeni
Jonathan Pereira
Nelson Lopes

Institutions

Cedars-Sinai Medical Center (US)
Innsbruck Medical University (AT)
Vita-Salute San Raffaele University (IT)
Inserm (FR)
Université Fédérale de Toulouse Midi-Pyrénées (FR)
Cornell University (US)
Istituti di Ricovero e Cura a Carattere Scientifico (IT)
French Clinical Research Infrastructure Network (FR)
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
University of Cincinnati (US)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000210440
Primary Topic: Genetic Neurodegenerative Diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study (P11-5.007)

Michele Tagliati, Fabrizio Stocchi, Alberto J. Espay, Harini Sarva et al.

Apr 7, 2025

Neurology

Genetic Neurodegenerative Diseases

article

Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study (P11-5.007)

Michele Tagliati, Fabrizio Stocchi, Alberto J. Espay, Harini Sarva, Olivier Rascol, Werner Poewe, Tami Yardeni, Jonathan Pereira, Nelson Lopes

April 7, 2025article en

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

Cedars-Sinai Medical Center (US), Innsbruck Medical University (AT), Vita-Salute San Raffaele University (IT), Inserm (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Cornell University (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT), French Clinical Research Infrastructure Network (FR), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Cincinnati (US)

Zero hunger

Openalex Percentile: Top 92%

Genetic Neurodegenerative Diseases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Quality of Life with 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612): QoL Results from a Phase 3 Randomized, Active-controlled Study (P11-5.007) — Michele Tagliati, Fabrizio Stocchi, et al. · Neurology (2025) | TGRS Research Map | TGRS